Supplementary Table S1.pdf (90.51 kB)
Supplementary Tables – PD-L1 Expression as a Prognostic Marker in Patients treated with Chemotherapy for Metastatic Non-Small Cell Lung Cancer
figure
posted on 2022-02-14, 16:57 authored by Figshare Future Science GroupFigshare Future Science Group, Rachel Woodford, Deborah Zhou, Sarah J Lord, Ian Marschner, Wendy A Cooper, Craig R Lewis, Thomas John, James Chih-Hsin Yang, Chee Khoon Lee|
Supplementary Table S1. PD-L1 Expression as a Prognostic Marker in Patients treated with Chemotherapy for Metastatic Non-Small Cell Lung Cancer Baseline patient characteristics and treatment received |
